Azabicyclo[4.1.0]heptane allosteric modulators of the M4 muscarinic acetylcholine receptor

The present invention is directed to azabicyclo[4.1.0]heptane compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatr...

Full description

Saved in:
Bibliographic Details
Main Authors Clausen, Dane James, Liu, Ping, Fells, James I, Mazzola, Jr., Robert D, Kozlowski, Joseph A
Format Patent
LanguageEnglish
Published 16.03.2021
Subjects
CHEMISTRY
DIAGNOSIS
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
IDENTIFICATION
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SURGERY
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to azabicyclo[4.1.0]heptane compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.
Bibliography:Application Number: US201816620046